Full-Time

Medical Operations Lead

Updated on 8/23/2026

Lucis

Lucis

11-50 employees

Subscription-based biomarker analysis for healthspan

No salary listed

London, UK + 2 more

More locations: Barcelona, Spain | Paris, France

Hybrid

The role is primarily based at the Paris hub, with regular travel to Paris for people based elsewhere in Europe; relocation support is available.

MD

Category
Operations & Logistics (1)
Required Skills
Risk Management

Get referred to Lucis

See people who can refer or advise you

Requirements
  • Hold a Doctor of Medicine degree.
  • Have meaningful experience in preventive medicine, general medicine, longevity medicine, cardiology, public health, or another relevant clinical field.
  • Have strong clinical judgment and be comfortable working across multiple medical domains.
  • Be highly organized and able to turn complex clinical knowledge into clear processes.
  • Think in systems, workflows, and decision trees rather than one-off solutions.
  • Be comfortable working with product, engineering, artificial intelligence, operations, and design teams.
  • Use artificial intelligence tools daily and naturally.
  • Balance medical rigor with speed and pragmatism.
  • Be proactive and take ownership beyond the boundaries of the role.
  • Be fluent in French and English, both spoken and written.
Responsibilities
  • Design, document, and improve the clinical workflows that power Lucis, from biomarker analysis to protocol creation and member follow-up.
  • Build systems that ensure clinical consistency across members and markets, clear ownership and review processes, fast escalation of complex or sensitive cases, reliable cross-functional collaboration, and continuous improvement based on member outcomes and operational feedback.
  • Create, structure, maintain, and operationalize Lucis clinical protocols.
  • Define protocol logic and maintain decision trees and clinical rules.
  • Review biomarker thresholds and expert ranges.
  • Translate medical reasoning into scalable workflows.
  • Ensure protocols remain aligned with current evidence.
  • Support the rollout of new biomarkers, health systems, and preventive-health programs.
  • Translate clinical reasoning into structured knowledge that Lucis systems can use.
  • Contribute to clinical prompts and reasoning frameworks, knowledge-base curation, protocol logic and decision systems, evaluation datasets and clinical quality checks, review of artificial-intelligence-generated medical outputs, and processes for identifying and correcting unsafe, inaccurate, or inconsistent outputs.
  • Define and maintain clinical review and sign-off processes, quality-control systems, documentation standards, audit trails, escalation procedures, medical risk-management processes, and clinical performance indicators.
  • Work directly with the product lead, medical team, artificial intelligence team, and operations team to make clinical processes medically rigorous, operationally efficient, and ready to scale across Europe.
  • Structure how medical knowledge is created, reviewed, documented, implemented, and continuously improved across the product.
Desired Qualifications
  • Experience in a startup, health technology company, clinical operations team, or technology-enabled care environment is strongly valued.
  • Additional language proficiency is a plus.

Lucis runs a European subscription service for preventive health, using regular blood tests to give people personalized insights aimed at extending their healthspan. The product relies on blood draws at 400+ partner labs and analyzes 180+ biomarkers, with AI interpretation reviewed by a medical team, presented through a dynamic dashboard and a prioritized, five-pillar action plan (nutrition, supplements, physical activity, sleep, mental health). It differentiates itself by combining data-driven AI analysis with medical expertise and longitudinal health tracking, rather than providing static reports, all within a European lab and physician network under a subscription model. The goal is to help individuals prevent chronic diseases and take proactive steps to improve long-term health.

Company Size

11-50

Company Stage

Series A

Total Funding

$28.6M

Headquarters

Paris, France

Founded

2023

Get referred to Lucis

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Lucis reported 10,000 users and 1,000,000 analyses by July 2026.
  • Seventy-five percent of six-month follow-ups improved three biomarkers without medication.
  • Expansion into Spain, Germany, and Italy by end-2026 extends the addressable market sharply.

What critics are saying

  • Thriva, Function Health, ZOE, and Neko Health crowd the same preventive-testing market.
  • Regulatory scrutiny on health data and clinical claims can force costly redesigns in 2026.
  • If repeat testing stays premium, Lucis becomes a one-off lab intermediary, not an endurance company.

What makes Lucis unique

  • Lucis pairs 110+ biomarkers with physician-reviewed AI and longitudinal tracking.
  • June 2026 Series A from Singular, General Catalyst, and Y Combinator validates category momentum.
  • Partner labs with Eurofins and Randox create European distribution without owning clinics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

3%

2 year growth

25%
Tech.eu
May 22nd, 2026
Lucis raises $20M Series A to scale AI-driven preventive health platform across Europe

Lucis, a preventive healthcare platform, has raised $20 million in Series A funding led by Singular, with participation from General Catalyst, Y Combinator and angel investors. The round follows an $8 million seed raised four months ago, bringing total funding to $28 million. Founded in 2025 by Maxime Berthelot and Baptiste Debever, Lucis analyses over 110 blood biomarkers and uses AI-powered insights reviewed by physicians to deliver personalised health guidance. Among users completing six-month follow-ups, 75% improved at least three biomarkers without medication, whilst over 80% opted to retest. The platform has reached 10,000 users across France, the UK, Ireland and Portugal, delivering over one million biomarker tests. Lucis plans to expand into Spain, Germany and Italy by end-2026.

Traders Union
Dec 16th, 2025
Lucis Life secures $8.5M seed round in healthcare and longevity sector

Lucis Life has raised $8.5 million in a seed funding round, led by founder Julien Bouteloup. The healthcare and longevity company achieved this milestone just one year after its launch. The funding round signals growing investor confidence in healthcare innovation. Bouteloup, known for his advocacy around addressing challenges beyond financial returns, has positioned Lucis Life as a leading innovator in the longevity sector. Details about participating investors and specific plans for the capital were not disclosed.

Maddyness
Dec 16th, 2025
Lucis raises funding from Y Combinator and Motier Ventures for predictive health platform

Lucis, a French health-tech startup, is entering the predictive health market with backing from Y Combinator and Motier Ventures. The company addresses a gap in Europe's healthcare system, which excels at treatment but falls short on prevention. Founded by CEO Maxime Berthelot, Lucis focuses on making blood tests more accessible and interpretable for comprehensive health monitoring. The startup identifies blood analysis as the best shortcut for understanding overall health status, but notes that access, cost and particularly interpretation remain significant barriers. Lucis joins a growing field of French longevity-focused startups, including Zoi, founded by former Emmanuel Macron adviser Ismaël Emelien, and Kor, which raised several million euros last year. The trend reflects increasing demand for preventive health solutions amongst tech entrepreneurs and consumers.

Zero
Apr 15th, 2025
You'd be crazy not to take collagen if you care about aging well

- Zero Health launched a Collagen at Zero Nutrition - a clean, 100% vegetarian formula for high absorption.